Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Novavax Inc (NVAX) reports a dramatic revenue increase and strategic collaborations, while navigating regulatory hurdles and ...

The FDA says it will allow three new color additives made from natural sources to be used in the nation's food supply.

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

M spin-off Solventum beat analysts' estimate for first-quarter profit on Thursday, helped by higher sales of its wound care, sterilization products.

U.S. Health Secretary Robert F. Kennedy Jr. defended new surgeon general pick Casey Means on Thursday from attacks from ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...